Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-02-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-3858PMID 19190324PMCID PMC2726651
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular basis of bortezomib resistance: proteasome subunit β5 (PSMB5) gene mutation and overexpression of PSMB5 protein

  2009cited by this paper
• Molecular basis of bortezomib resistance: proteasome subunit beta5 (PSMB5) gene mutation and overexpression of PSMB5 protein.

  2008cited by this paper
• Dual function of pancreatic endoplasmic reticulum kinase in tumor cell growth arrest and survival.

  2008cited by this paper
• Identification and characterization of endoplasmic reticulum stress-induced apoptosis in vivo.

  2008cited by this paper
• Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development.

  2008cited by this paper
• ATF6α-Rheb-mTOR signaling promotes survival of dormant tumor cells in vivo

  2008cited by this paper
• Expression and splicing of the unfolded protein response gene XBP‐1 are significantly associated with clinical outcome of endocrine‐treated breast cancer

  2008cited by this paper
• Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells.

  2007cited by this paper
• ER stress triggers apoptosis by activating BH3-only protein Bim.

  2007cited by this paper
• Inhibitors of the heat shock response: Biology and pharmacology

  2007cited by this paper
• The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas.

  2007cited by this paper
• Inhibition of Proliferation by PERK Regulates Mammary Acinar Morphogenesis and Tumor Formation

  2007influential reference
• GRP78 induction in cancer: therapeutic and prognostic implications.

  2007cited by this paper
• Combination of proteasome inhibitors bortezomib and NPI-0052 trigger in vivo synergistic cytotoxicity in multiple myeloma.

  2007cited by this paper
• That which does not kill me makes me stronger: adapting to chronic ER stress.

  2007influential reference
• Selective Inhibition of Eukaryotic Translation Initiation Factor 2α Dephosphorylation Potentiates Fatty Acid-induced Endoplasmic Reticulum Stress and Causes Pancreatic β-Cell Dysfunction and Apoptosis*

  2006cited by this paper
• Functional coupling of p38-induced up-regulation of BiP and activation of RNA-dependent protein kinase-like endoplasmic reticulum kinase to drug resistance of dormant carcinoma cells.

  2006influential reference
• Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.

  2006cited by this paper
• Inhibition of p38α MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

  2006cited by this paper
• Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells.

  2006influential reference
• Activation of the endoplasmic reticulum stress pathway is associated with survival of myeloma cells

  2006cited by this paper
• Proteasome inhibitor therapy in multiple myeloma

  2005influential reference
• A Selective Inhibitor of eIF2α Dephosphorylation Protects Cells from ER Stress

  2005influential reference
• Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM)

  2005cited by this paper
• A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress.

  2005cited by this paper
• Phase I trial of the proteasome inhibitor bortezomib in patients with advanced solid tumors with observations in androgen-independent prostate cancer.

  2004cited by this paper
• Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma Cells

  2004influential reference
• ERK(MAPK) activity as a determinant of tumor growth and dormancy; regulation by p38(SAPK).

  2003influential reference
• ERKMAPK Activity as a Determinant of Tumor Growth and Dormancy; Regulation by p38SAPK

  2003cited by this paper
• Regulation of Antioxidant Metabolism by Translation Initiation Factor 2α

  2001cited by this paper
• Flow cytometric analysis of cell division history using dilution of carboxyfluorescein diacetate succinimidyl ester, a stably integrated fluorescent probe.

  2001cited by this paper
• PERK mediates cell-cycle exit during the mammalian unfolded protein response.

  2000cited by this paper
• Identification of Caspase 3-mediated Cleavage and Functional Alteration of Eukaryotic Initiation Factor 2α in Apoptosis*

  2000cited by this paper
• Mammalian unfolded protein response inhibits cyclin D1 translation and cell-cycle progression.

  1999cited by this paper

• The Integrated Stress Response in Cancer: Paradox and Therapeutic Promise

  2026cites this paper
• Cancer Cell Dormancy in the Bone Microenvironment

  2025cites this paper
• Signal transduction pathways controlling Ins2 gene activity and beta cell state transitions

  2025cites this paper
• Impact of proteostasis workload on sensitivity to proteasome inhibitors in multiple myeloma

  2025cites this paper
• Multiple myeloma associated long non-coding RNA PLUM confers chemoresistance by enhancing PRC2 mediated UPR pathway activation

  2025cites this paper
• Syrosingopine and UK5099 synergistically suppress non-small cell lung cancer by activating the integrated stress response

  2024cites this paper
• Exploiting Translation Machinery for Cancer Therapy: Translation Factors as Promising Targets

  2024cites this paper
• Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma

  2024cites this paper
• Les voies de signalisation régulées par la disponibilité en acides aminés : contrôle de fonctions physiologiques et impacts en santé

  2024cites this paper
• The ubiquitin-proteasome system in the regulation of tumor dormancy and recurrence.

  2024cites this paper
• Expression of the chemokine receptor CCR1 decreases sensitivity to bortezomib in multiple myeloma cell lines.

  2024cites this paper
• O-GlcNAcylation of ribosome-associated proteins is concomitant with translational reprogramming during proteotoxic stress

  2024cites this paper
• Role of stress granules in tumorigenesis and cancer therapy.

  2023cites this paper
• Inhibition of EIF2α Dephosphorylation Decreases Cell Viability and Synergizes with Standard-of-Care Chemotherapeutics in Head and Neck Squamous Cell Carcinoma

  2023influential citation
• Inhibition of GCN2 Reveals Synergy with Cell-Cycle Regulation and Proteostasis

  2023cites this paper
• A PERK-Specific Inhibitor Blocks Metastatic Progression by Limiting Integrated Stress Response-Dependent Survival of Quiescent Cancer Cells.

  2023cites this paper
• The integrated stress response in cancer progression: a force for plasticity and resistance

  2023cites this paper
• Targeting CAM-DR and Mitochondrial Transfer for the Treatment of Multiple Myeloma

  2022cites this paper
• The role of the bone microenvironment in regulating myeloma residual disease and treatment

  2022cites this paper
• RNA interference screens discover proteases as synthetic lethal partners of PI3K inhibition in breast cancer cells

  2022cites this paper
• Tumor Dormancy: Biologic and Therapeutic Implications

  2022cites this paper
• Amino acid restriction induces a long non‐coding RNA UBA6‐AS1 to regulate GCN2‐mediated integrated stress response in breast cancer

  2022cites this paper
• The unfolded protein response and the biology of uveal melanoma.

  2022cites this paper
• Systems level profiling of chemotherapy-induced stress resolution in cancer cells reveals druggable trade-offs

  2021cites this paper
• EZH2 inhibition enhances TRAIL responses in multiple myeloma but not in quiescent cells

  2021cites this paper
• Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapy

  2021cites this paper
• PERK inhibition blocks metastasis initiation by limiting UPR-dependent survival of dormant disseminated cancer cells

  2021cites this paper
• Stress Granules Involved in Formation, Progression and Metastasis of Cancer: A Scoping Review

  2021influential citation
• Tumor dormancy in bone

  2020cites this paper
• Actionable Strategies to Target Multiple Myeloma Plasma Cell Resistance/Resilience to Stress: Insights From “Omics” Research

  2020cites this paper
• Carfilzomib‐induced hemolysis is noticeably common but rarely shows features of thrombotic microangiopathy: A retrospective study

  2020cites this paper
• Development of Resistance to Endoplasmic Reticulum Stress-Inducing Agents in Mouse Leukemic L1210 Cells

  2020cites this paper
• Induction of ER Stress in Acute Lymphoblastic Leukemia Cells by the Deubiquitinase Inhibitor VLX1570

  2020cites this paper
• Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor

  2020cites this paper
• The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma

  2020cites this paper
• Targeting dormant tumor cells to prevent cancer recurrence

  2020cites this paper
• In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma

  2020cites this paper
• Drug screening with a novel tumor-derived cell line identified alternative therapeutic options for patients with atypical teratoid/rhabdoid tumor

  2020cites this paper
• Genome-wide translation patterns in gliomas: An integrative view.

  2020cites this paper
• Endoplasmic reticulum stress in the cellular release of damage-associated molecular patterns.

  2020cites this paper
• Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15

  2019cites this paper
• Stress granule: A promising target for cancer treatment

  2019cites this paper
• An Integrated Stress Response Agent that Modulates DR5-Dependent TRAIL Synergy Reduces Patient-Derived Glioma Stem Cell Viability

  2019cites this paper
• Psammaplysin F increases the efficacy of bortezomib and sorafenib through regulation of stress granule formation.

  2019cites this paper
• Correction: Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells

  2019cites this paper
• An integrated stress response via PKR suppresses HER2+ cancers and improves trastuzumab therapy

  2019cites this paper
• Excess hepsin proteolytic activity limits oncogenic signaling and induces ER stress and autophagy in prostate cancer cells

  2019cites this paper
• Proteasome-mediated remodeling of the proteome and phosphoproteome during kiwifruit pollen germination.

  2019cites this paper
• The regulatory protein GADD34 inhibits TRAIL-induced apoptosis via TRAF6/ERK-dependent stabilization of myeloid cell leukemia 1 in liver cancer cells

  2019cites this paper
• Research progress on therapeutic targeting of quiescent cancer cells

  2019cites this paper
• Recent insights into PERK-dependent signaling from the stressed endoplasmic reticulum

  2019cites this paper
• Emerging Topics on Disseminated Cancer Cell Dormancy and the Paradigm of Metastasis

  2018cites this paper
• Therapeutic Opportunities in Eukaryotic Translation.

  2018cites this paper
• Beyond molecular tumor heterogeneity: protein synthesis takes control

  2018cites this paper
• Translational Control in Cancer.

  2018cites this paper
• Investigation of TRAIL resistance in lung cancer cell lines

  2018cites this paper
• Bortezomib sensitizes multiple myeloma to NK cells via ER-stress-induced suppression of HLA-E and upregulation of DR5

  2018cites this paper
• Epigenetic Regulation of Cancer Dormancy as a Plasticity Mechanism for Metastasis Initiation

  2017cites this paper
• Translational control and the cancer cell response to stress.

  2017cites this paper
• Understanding the role of stress granules in the inner ear

  2017cites this paper
• Role of the unfolded protein response in tumor cell characteristics and cancer outcome

  2017cites this paper
• YM155 exerts potent cytotoxic activity against quiescent (G0/G1) multiple myeloma and bortezomib resistant cells via inhibition of survivin and Mcl-1

  2017influential citation
• Metastatic Cell Dormancy and Re-activation: An Overview on Series of Molecular Events Critical for Cancer Relapse.

  2017cites this paper
• The eIF2-alpha kinase HRI: a potential target beyond the red blood cell

  2017cites this paper
• HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells

  2017cites this paper
• Recent insights into PERK-dependent signaling from the stressed endoplasmic reticulum

  2017cites this paper
• Salubrinal-Mediated Upregulation of eIF2α Phosphorylation Increases Doxorubicin Sensitivity in MCF-7/ADR Cells

  2016cites this paper
• A Case-Matched Gender Comparison Transcriptomic Screen Identifies eIF4E and eIF5 as Potential Prognostic Markers in Male Breast Cancer

  2016cites this paper
• Next-generation proteasome inhibitor oprozomib synergizes with modulators of the unfolded protein response to suppress hepatocellular carcinoma

  2016cites this paper
• Translation Initiation Factors: Reprogramming Protein Synthesis in Cancer.

  2016cites this paper
• Adaptation to Amino Acid Availability

  2016cites this paper
• Subcellular proteomics analysis of different stages of colorectal cancer cell lines

  2016cites this paper
• Phenotypic and genomic analysis of multiple myeloma minimal residual disease tumor cells: a new model to understand chemoresistance.

  2016cites this paper
• Reprogramming of Molecular Switching Events in UPR Driven ER Stress: Scope for Development of Anticancer Therapeutics.

  2016cites this paper
• Myelomatous plasma cells display an aberrant gene expression pattern similar to that observed in normal memory B cells.

  2015cites this paper
• EMT, CTCs and CSCs in tumor relapse and drug-resistance

  2015cites this paper
• Identification of markers that functionally define a quiescent multiple myeloma cell sub-population surviving bortezomib treatment

  2015influential citation
• An inhibitor of ubiquitin conjugation and aggresome formation† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc01351h Click here for additional data file.

  2015cites this paper
• Cantharidin Induces Apoptosis Through the Calcium/PKC-Regulated Endoplasmic Reticulum Stress Pathway in Human Bladder Cancer Cells.

  2015cites this paper
• Targeting the translation machinery in cancer

  2015cites this paper
• Proteomic profiling of naïve multiple myeloma patient plasma cells identifies pathways associated with favourable response to bortezomib‐based treatment regimens

  2015cites this paper
• Ricolinostat (ACY‐1215) induced inhibition of aggresome formation accelerates carfilzomib‐induced multiple myeloma cell death

  2015cites this paper
• Stress Response Pathways in Cancer

  2015cites this paper
• Harnessing Noxa demethylation to overcome Bortezomib resistance in mantle cell lymphoma

  2015cites this paper
• [Adaptation to the availability of essential amino-acids: role of GCN2/eIF2α/ATF4 pathway].

  2015cites this paper
• Cellular Plasticity, Cancer Stem Cells and Metastasis

  2015cites this paper
• Impact on angiogenesis and ER stress and its effect on chemoresistance through PlGF inhibition in a mouse model of hepatocellular carcinoma

  2015cites this paper
• Characterization of a PERK Kinase Inhibitor with Anti-Myeloma Activity

  2015cites this paper
• Contact Normalization or Escape from the Matrix

  2015cites this paper
• Endoplasmic Reticulum Stress in Multiple Myeloma: From Molecular Mechanisms to Therapeutic Opportunities

  2015cites this paper
• Effect of 5-Fluorouracil on translational regulation in colorectal cancer cells

  2015cites this paper
• Systems Biology of Cancer: Regulation and dysregulation of protein synthesis in cancer cells

  2015cites this paper
• Endoplasmic reticulum stress in malignancy.

  2014cites this paper
• Addicted to secrete - novel concepts and targets in cancer therapy.

  2014cites this paper
• The roles of protein expression in synaptic plasticity and memory consolidation

  2014cites this paper
• Cambios en los perfiles de expresión génica en condiciones fisiológicas versus patológicas en el sistema hematopoyético

  2014cites this paper
• Polyphenon E(R), a standardized green tea extract, induces endoplasmic reticulum stress, leading to death of immortalized PNT1a cells by anoikis and tumorigenic PC3 by necroptosis.

  2014cites this paper
• Fucoidan Induces Cancer Cell Apoptosis by Modulating the Endoplasmic Reticulum Stress Cascades

  2014cites this paper
• Proteotoxic Stress and Proteasome Inhibitor Efficacy and Resistance

  2014cites this paper
• Translation factors and ribosomal proteins control tumor onset and progression: how?

  2014cites this paper